1,051
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Persimmon vinegar and its fractions protect against alcohol-induced hepatic injury in rats through the suppression of CYP2E1 expression

, , , , &
Pages 2437-2442 | Received 24 Nov 2015, Accepted 23 Feb 2016, Published online: 04 Apr 2016

References

  • Albano E. 2008. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med. 29:9–16.
  • Arteel GE. 2003. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology. 124:778–790.
  • Ding RB, Tian K, Huang LL, He CW, Jiang Y, Wang YT, Wan JB. 2012. Herbal medicines for the prevention of alcoholic liver disease: a review. J Ethnopharmacol. 144:457–465.
  • Hoek JB, Pastorino JG. 2002. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol. 27:63–68.
  • Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E, Szabo G. 2008. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology. 48:1224–1231.
  • Hu S, Yin S, Jiang X, Huang D, Shen G. 2009. Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis. Eur J Pharmacol. 616:287–292.
  • Khan AQ, Nafees S, Sultana S. 2011. Perillyl alcohol protects against ethanol induced acute liver injury in Wistar rats by inhibiting oxidative stress, NFκ-B activation and proinflammatory cytokine production. Toxicology. 279:108–114.
  • Kim K. 1999. Effects of sport-drink with persimmon vinegar on ethanol oxidation and recovery of physiological function. Exerc Sci. 8:495–505.
  • Leung TM, Nieto N. 2013. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol. 58:395–398.
  • Lieber CS. 2004. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol. 34:9–19.
  • Lieber CS. 2005. Metabolism of alcohol. Clin Liver Dis. 9:1–35.
  • Masalkar PD, Abhang SA. 2005. Oxidative stress and antioxidant status in patients with alcoholic liver disease. Clin Chim Acta. 355:61–65.
  • Moon YJ, Cha YS. 2008. Effects of persimmon-vinegar on lipid metabolism and alcohol clearance in chronic alcohol-fed rats. J Med Food. 11:38–45.
  • Nanji AA, Miao L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, Peters D, Tahan SR, Dannenberg AJ. 1997. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology. 112:943–951.
  • Neuman MG. 2003. Cytokines-central factors in alcoholic liver disease. Alcohol Res Health. 27:307–316.
  • Park HY, Ha SK, Eom H, Choi I. 2013. Narirutin fraction from citrus peels attenuates alcoholic liver disease in mice. Food Chem Toxicol. 55:637–644.
  • Singleton VL, Orthofer R, Lamuela-Raventos RM. 1999. Methods in enzymology. San Diego (CA): Academic Press.
  • Takahashi T, Lasker JM, Rosman AS, Lieber CS. 1993. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology. 17:236–245.
  • Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS. 1989. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology. 10:437–446.
  • Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG. 2001. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology. 34:101–108.
  • Vidali M, Stewart SF, Albano E. 2008. Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury. Trends Mol Med. 14:63–71.
  • Wang HJ, Gao B, Zakhari S, Nagy LE. 2012. Inflammation in alcoholic liver disease. Annu Rev Nutr. 32:343–368.
  • Williams R. 2006. Global challenges in liver disease. Hepatology. 44:521–526.
  • Wu D, Cederbaum AI. 2003. Alcohol, oxidative stress, and free radical damage. Alcohol Res Health. 27:277–284.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.